Procedure Guide | Interventional Pain Management | Lumbosacral Spine

Developed by GoHealthcare Practice Solutions

Caudal Epidural Steroid Injection

Medical Necessity, Prior Authorization, Documentation, Coding, Reimbursement, and Denial Prevention

A comprehensive operational reference for physicians, APPs, prior authorization specialists, utilization management nurses, practice administrators, coding teams, revenue cycle professionals, ambulatory surgery centers, hospitals, and healthcare leaders.

Request Help View Our Case Studies

Educational and operational reference only. Verify all coverage, coding, documentation, authorization, and policy requirements with the applicable payer and current regulatory sources. This resource is not a procedural technique manual and does not replace clinical judgment, licensed coding resources, payer contracts, or official policy.

Procedure FamilyEpidural Procedures

Primary Procedure NameCaudal Epidural Steroid Injection

Common Short NameCaudal ESI

Primary CPT Focus62323 when performed with fluoroscopy or CT

Policy Currency DateJuly 27, 2026

Document StatusPublication-ready operational resource; Framework Version 1.3; verify live payer policy before use

GoHealthcare Performance

Specialty Healthcare Operations Backed by Measurable Results

GoHealthcare Practice Solutions combines MSK specialty expertise, payer intelligence, clinical documentation discipline, prior authorization, and revenue-cycle execution.

25+ Yearsin healthcare operations and management

500+physicians and practice groups served

3.5M+prior authorization requests reviewed, submitted, and processed

98%reported prior authorization approval rate

<1%of reported cases require peer-to-peer review

2%reported prior authorization denial rate

Request Help Explore 22 Healthcare Case Studies

Company-reported performance metrics published by GoHealthcare Practice Solutions. Results vary by client, payer, specialty, case mix, documentation quality, and service scope. Case study library: https://www.gohealthcarellc.com/case-studies.html

Resource Use

Foundational Naming Rule

A caudal epidural steroid injection is a lumbosacral epidural procedure performed through the sacral hiatus. It is not a cervical or thoracic caudal injection. To avoid abbreviation ambiguity, this page uses "caudal ESI" rather than "CESI," which some organizations use for cervical epidural steroid injection.

The operational success of a caudal ESI depends on a coherent diagnostic episode: the symptom pattern, examination, imaging, conservative-care history, selected approach, authorization, procedure note, outcome measurement, and claim must tell the same story.

How to Use This Resource

This procedure page is designed for physicians, advanced practice providers, prior authorization specialists, utilization management nurses, practice administrators, coders, revenue cycle teams, ambulatory surgery centers, hospitals, and healthcare executives. It focuses on operational and reimbursement integrity rather than procedural technique. It is not a substitute for the treating clinician's judgment, current payer policy, coding advice, or legal counsel.

Policy Hierarchy

Apply the member's benefit plan and live payer policy first. For Original Medicare, identify the patient's Medicare Administrative Contractor (MAC), current Local Coverage Determination (LCD), and related billing and coding article. For commercial plans, confirm whether the payer delegates review to a utilization management vendor. Authorization is not a guarantee of payment.

Procedure Navigation

Explore the Complete Caudal ESI Guide

Use the grouped links below to move directly to each section. See GoHealthcare's applied operational work in the Healthcare Operations Case Study Library.

Clinical Foundation

1. Overview
2. Evidence at a Glance
3. Procedure Overview
4. Relevant Anatomy
5. Clinical Indications

Selection and Care Pathway

6. Patient Selection
7. Contraindications and Precautions
8. Medical Necessity
9. Conservative Treatment Requirements
10. Diagnostic Prerequisites and Care-Pathway Sequencing

Medicare and Commercial Coverage

11. CMS National Coverage Determinations and National Guidance
12. Medicare LCDs and MAC Guidance
13. Medicare Billing and Coding Articles
14. CMS WISeR Model: Prior Authorization and Prepayment Review
15. Commercial Payer Policies

BCBS, UM, Evidence, and Authorization

16. Blue Cross Blue Shield Policy Perspective
17. Delegated Utilization Management Guidelines
18. Evidence-Based Clinical and Specialty-Society Guidelines
19. Policy and Guideline Comparison Matrix
20. Prior Authorization Workflow

Documentation and Coding

21. Clinical Documentation Requirements
22. Documentation Pearls
23. CPT and HCPCS Coding
24. ICD-10-CM Crosswalk
25. Modifiers, Units, NCCI, MUE, and Place of Service

Reimbursement, Compliance, and Denials

26. Reimbursement Considerations
27. Integrated Compliance and Quality Controls
28. Denial Prevention
29. Common Denial Reasons
30. Appeals and Peer-to-Peer Review

Operations and GoHealthcare Strategy

31. Operational Workflow
32. Payer Perspective
33. Clinical Pearls
34. GoHealthcare Perspective
35. GoHealthcare Insights

FAQs, Related Procedures, and Sources

36. Key Takeaways
37. Frequently Asked Questions
38. Related Procedures
39. References and Policy Sources
40. Disclaimer

01

GoHealthcare MSK Specialty Procedure Library

Overview

A caudal epidural steroid injection delivers medication into the lumbosacral epidural space through the sacral hiatus. The approach is used for selected patients with radicular pain, radiculopathy, neurogenic claudication, post-laminectomy or post-surgical pain syndromes, and other qualifying conditions when the clinical presentation, diagnostic information, prior treatment, and payer requirements support medical necessity. The procedure is generally reported within the lumbar/sacral interlaminar code family when imaging guidance is used.

Operationally, caudal ESI is deceptively complex. The procedure name is simple, but the authorization and claim depend on multiple linked elements: the diagnosis must describe a covered pain generator; the symptoms and neurologic findings must be anatomically concordant; the record must establish functional impact; conservative treatment must be documented with dates and outcomes; imaging requirements vary by payer; prior injection response must be measured using the same pain or functional instrument; frequency limits must be checked across all epidural approaches in the same spinal region; and the authorization must match the final code, region, site of service, rendering provider, and date of service.

A high-performing organization treats caudal ESI as an episode of care, not as a scheduling transaction. The episode begins when the clinician evaluates the patient and ends only after the outcome is documented, the claim is adjudicated, and the next care decision is supported by objective data.

Back to Procedure Navigation

02

GoHealthcare MSK Specialty Procedure Library

Evidence at a Glance

Domain	Operational conclusion	Source category
Clinical evidence	Epidural steroid injections may provide modest, primarily short-term improvement in pain and disability for selected patients with radiculopathy. Evidence is less consistent for long-term benefit and for spinal stenosis outcomes. Route-specific evidence is heterogeneous.	Evidence-based recommendation; AAN systematic review [18]
Medicare coverage	Coverage is primarily governed through MAC LCDs and related billing and coding articles rather than a single ESI-specific national coverage determination. Common LCD elements include qualifying radicular conditions, significant functional impact, conservative care, image guidance, response thresholds for repeats, and frequency limits.	Medicare policy [1-4]
Commercial coverage	Major policies generally require radicular symptoms, functional impairment, conservative treatment, and image guidance. Imaging and repeat-injection thresholds vary.	Commercial payer policy [6-9]
2026 Medicare prior authorization	In selected WISeR states, Original Medicare CPT 62323 used for ESI is subject to an optional prior-authorization pathway or prepayment medical review.	CMS model requirement [5]
Coding	The principal 2026 code for a single image-guided lumbar/sacral interlaminar or caudal injection is CPT 62323. Image guidance is integral to that code.	Coding framework; verify current CPT and payer edits
Operational risk	The most common preventable failures are incomplete conservative-care history, nonconcordant diagnosis/imaging, missing baseline and repeat outcome scores, frequency miscounts across approaches, and authorization-to-claim mismatch.	GoHealthcare operational insight

Do Not Promise a Series

Neither Medicare nor major commercial policies should be operationalized as an automatic "series of three." Each repeat injection requires a new medical-necessity decision based on the patient's documented response, the applicable timing rule, regional frequency limits, and the live payer policy.

Back to Procedure Navigation

03

GoHealthcare MSK Specialty Procedure Library

Procedure Overview

The caudal route enters the epidural space through the sacral hiatus and allows medication to spread cephalad within the lumbosacral epidural space. The treating physician determines whether the caudal approach is clinically appropriate based on the patient's symptoms, anatomy, prior surgery, imaging, target distribution, safety considerations, and alternative approaches. This resource does not prescribe needle technique, medication selection, dose, or procedural maneuvers.

From an operations perspective, the route must be identified precisely. "Lumbar epidural," "sacral injection," and "caudal block" are not interchangeable descriptions for authorization or coding. A caudal ESI should be ordered, authorized, scheduled, documented, and billed consistently as a caudal epidural injection within the lumbar/sacral region. A sacroiliac joint injection, coccygeal injection, ganglion impar block, or sacral transforaminal injection is a different procedure with different coding and coverage rules.

Where the caudal approach may fit in the care pathway

• Selected lumbosacral radicular presentations. The route may be considered when symptoms and objective findings indicate a qualifying lumbar or sacral nerve-root process.
• Multilevel or bilateral symptom distribution. The physician may choose the caudal route when broader epidural spread is clinically desired; this is not a universal payer indication by itself.
• Post-surgical anatomy. The route may be considered when prior lumbar surgery or altered anatomy affects approach selection, provided the diagnosis and payer criteria are met.
• Alternative to another epidural approach. The decision should explain why caudal rather than lumbar interlaminar or transforaminal access is clinically appropriate for the individual patient.
• Temporary symptom control to advance function. The treatment plan should connect the injection to rehabilitation, home exercise, medication optimization, or another defined functional objective.

Back to Procedure Navigation

04

GoHealthcare MSK Specialty Procedure Library

Relevant Anatomy

The sacral hiatus is an opening at the caudal end of the sacral canal. Through this access point, medication can enter the epidural space and distribute toward the lumbar and sacral nerve roots. The clinical target is not the sacroiliac joint and not a peripheral sacral nerve outside the epidural space. This distinction matters because payer policies, procedure coding, imaging documentation, and diagnosis selection depend on the actual anatomic target.

Anatomic variation, prior surgery, epidural scarring, stenosis, body habitus, and other patient-specific factors may affect approach selection and medication distribution. These clinical considerations belong in the physician's decision-making, not in a generic authorization template. The authorization team should capture the physician's rationale without inventing or extrapolating anatomy that is not documented.

Back to Procedure Navigation

05

GoHealthcare MSK Specialty Procedure Library

Clinical Indications

Coverage is usually strongest when the record demonstrates a radicular syndrome or neurogenic claudication that is concordant with the examination and available diagnostic information. Medicare LCDs commonly recognize radiculopathy, radicular pain, and/or neurogenic claudication associated with disc herniation, osteophytes or osteophyte complexes, severe degenerative disc disease producing foraminal or central stenosis, post-laminectomy syndrome, and acute herpes zoster-associated pain, subject to the full LCD requirements. Commercial policies use similar concepts but may define the imaging, duration, and conservative-treatment requirements differently.

• Lumbar or lumbosacral radicular pain. Pain follows a nerve-root distribution and is supported by history and examination.
• Lumbar or lumbosacral radiculopathy. The record may include sensory, motor, or reflex findings that support nerve-root dysfunction.
• Neurogenic claudication. Symptoms and functional limitations are associated with central or foraminal stenosis and are supported by the clinical record.
• Post-laminectomy or persistent spinal pain after surgery. The record should distinguish the current radicular or neuropathic presentation from nonspecific postoperative axial pain.
• Acute herpes zoster-associated pain. This is recognized in certain Medicare policies; payer-specific criteria and timing must be verified.

Coverage Vulnerability

Isolated axial low-back pain without radicular features, nonspecific degenerative findings, or a diagnosis that does not explain the symptom distribution is frequently noncovered or denied. Do not attempt to solve this problem by selecting a more favorable diagnosis code. The documentation must support the true clinical condition.

Back to Procedure Navigation

06

GoHealthcare MSK Specialty Procedure Library

Patient Selection

Appropriate patient selection requires more than a diagnosis code. The medical record should establish that the patient's symptoms, examination, diagnostic findings, functional limitations, prior treatment, and planned procedure are clinically coherent. A payer reviewer should be able to understand why an epidural procedure is being requested, why the caudal route was selected, what outcome is expected, and how the result will influence the next step in care.

Selection element	What the record should show	Operational test
Symptom pattern	Leg-dominant or lumbosacral radicular symptoms, neurogenic claudication, or another covered presentation.	Can the reviewer identify the distribution, laterality, severity, and duration?
Objective findings	Relevant neurologic or functional findings, when present, and a focused physical examination.	Does the examination support the stated diagnosis rather than only "back pain"?
Diagnostic concordance	Imaging or other testing when required by the payer, interpreted in relation to the patient's symptoms.	Does the report identify a lesion that reasonably explains the clinical pattern?
Functional impact	Specific limits in walking, standing, sleep, work, self-care, rehabilitation, or other activities.	Is a baseline pain or function instrument documented and reproducible?
Prior treatment	Dated conservative care, adherence, intolerance, contraindication, or failure.	Could an auditor determine what was tried, for how long, and with what result?
Approach rationale	Clinical reason the caudal route is appropriate.	Is the route rationale documented without boilerplate?
Outcome plan	Measurable target and next step after the injection.	Will the follow-up note answer whether the injection changed pain, function, medication use, or care planning?

Back to Procedure Navigation

07

GoHealthcare MSK Specialty Procedure Library

Contraindications and Precautions

The treating clinician must evaluate absolute and relative contraindications using current clinical standards, patient-specific risk, medication labeling, and facility policy. Coverage policies commonly identify active infection, epidural abscess, spinal neoplasm in the proposed treatment area, rapidly progressive neurologic deficit, or other conditions requiring urgent evaluation as reasons not to proceed with a routine ESI. Anticoagulant and antiplatelet management requires individualized coordination under current specialty guidance and the prescribing clinician's direction.

• Infection and systemic illness. Document screening for active systemic infection, local infection, or suspected epidural infection.
• Neurologic red flags. Progressive weakness, bowel or bladder dysfunction, saddle anesthesia, or other urgent findings require escalation rather than routine authorization processing.
• Bleeding risk. Document medication reconciliation, relevant coagulation risk, and the clinician's plan. Prior authorization staff should not provide medication-hold instructions.
• Allergy and contrast considerations. Document relevant contrast, medication, or antiseptic allergies and the physician's alternative plan when applicable.
• Pregnancy. Imaging and medication decisions require clinician assessment and facility protocol.
• Metabolic and immunologic considerations. Diabetes, immune suppression, and repeated corticosteroid exposure may require additional risk-benefit documentation.
• Sedation risk. Routine moderate or deep sedation is often not considered medically necessary for ESI. Any exception should be supported by a patient-specific rationale and payer rules.

The FDA has required warnings regarding rare but serious neurologic events associated with epidural corticosteroid injections. Corticosteroids are not FDA-approved specifically for epidural administration. This safety context supports careful informed consent and clinical governance, but it does not itself establish or negate payer coverage. [21]

Back to Procedure Navigation

08

GoHealthcare MSK Specialty Procedure Library

Medical Necessity

Medical necessity is the integrated rationale for the procedure. It is not a checklist pasted into the note. The record should explain the condition being treated, why it is causing the patient's symptoms and functional impairment, what noninvasive treatment has been attempted, why an epidural intervention is reasonable now, why the caudal route is appropriate, and what measurable outcome will determine success or failure.

Core medical-necessity elements

• Covered clinical condition. A diagnosis and symptom pattern that the applicable policy recognizes.
• Severity and functional impairment. The symptoms materially affect quality of life or function and are measured at baseline.
• Duration. The condition has persisted for the policy-required period unless a recognized exception applies.
• Conservative care. The patient failed, could not tolerate, or had a contraindication to required noninvasive treatment.
• Concordant diagnostic information. Imaging or other testing is present when required and supports the clinical presentation.
• Approach selection. The clinician documents why the caudal route is reasonable for the patient.
• Active treatment plan. The injection is linked to rehabilitation, home exercise, or another defined care objective.
• Repeat criteria. For a repeat injection, the prior result is documented using the same pain or functional scale, with duration of benefit and the reason another injection is appropriate.

What does not establish medical necessity by itself

• MRI abnormalities without a matching clinical syndrome.
• A pain score without functional impact, examination, diagnosis, and treatment history.
• A prior authorization approval from an earlier episode.
• A standing order for a predetermined injection series.
• Patient preference alone.
• Failure of medication without documentation of other required conservative measures.
• A general statement that "conservative care failed" without dates, modalities, adherence, and outcomes.
• A code that appears on a payer list when the actual record does not support that diagnosis.

Back to Procedure Navigation

09

GoHealthcare MSK Specialty Procedure Library

Conservative Treatment Requirements

Most Medicare and commercial policies require a documented trial of noninvasive conservative care, commonly at least four weeks, unless the patient could not tolerate treatment, had a contraindication, or qualified for a policy-specific exception. The exact requirement is payer- and plan-specific. Some commercial policies define allowable combinations of medication, activity modification, physical therapy, clinician-directed home exercise, or other interventions. A single undocumented recommendation is rarely sufficient.

Documentation field	Minimum operational content	Weak language to avoid
Dates	Start date, end date or ongoing status, and total duration.	"Tried PT."
Modality	Physical therapy, home exercise, activity modification, medication, or other noninvasive treatment.	"Conservative care."
Adherence	Attendance, participation, or reason treatment could not be completed.	"Failed."
Outcome	No meaningful benefit, temporary benefit, intolerance, worsening, or contraindication.	"Did not work."
Clinical relevance	How the response supports the decision to proceed with ESI.	"Needs injection."
Exception	Why waiting or completing a usual modality was not clinically appropriate, when permitted by policy.	No explanation.

GoHealthcare operational standard: capture conservative-care data in discrete fields during intake or clinical preparation, then have the clinician validate it. This prevents authorization teams from searching across multiple notes and reduces the risk of submitting incomplete or contradictory histories.

Back to Procedure Navigation

10

GoHealthcare MSK Specialty Procedure Library

Diagnostic Prerequisites and Care-Pathway Sequencing

A caudal ESI is generally therapeutic, not a diagnostic gateway procedure. The record should identify the working diagnosis and the treatment objective before the injection. The result should then inform continuation of conservative management, repeat ESI consideration, surgical evaluation, alternative intervention, or cessation of ineffective treatment.

1. Confirm the clinical syndrome and screen for urgent or non-epidural pain generators.
2. Confirm that the diagnosis, examination, and imaging requirements are concordant.
3. Complete and document required conservative treatment or a policy-recognized exception.
4. Determine the most appropriate epidural approach and document why the caudal route is selected.
5. Obtain authorization, when required, for the exact code, region, provider, site of service, and date range.
6. Perform the procedure under the required imaging modality and document the procedure accurately.
7. Measure outcome using the same baseline instrument, including duration of benefit and functional change.
8. Determine the next step based on response and payer rules; do not schedule automatic repeats.

Back to Procedure Navigation

11

GoHealthcare MSK Specialty Procedure Library

CMS National Coverage Determinations and National Guidance

No procedure-specific National Coverage Determination (NCD) establishes a single nationwide coverage standard for caudal epidural steroid injection performed for pain management. The active Medicare LCDs reviewed for this resource identify no associated ESI-specific NCD. Coverage therefore depends principally on the applicable Medicare Administrative Contractor's LCD and related billing and coding article, together with the Social Security Act reasonable-and-necessary standard, CMS manuals, national coding rules, and the beneficiary's specific circumstances. The absence of an NCD is not automatic coverage and is not permission to ignore local policy. [1-8]

National-versus-Local Rule

For Original Medicare, begin with the beneficiary's MAC and the policy version effective on the date of service. A national CMS page, code descriptor, or general Medicare manual cannot be used to override a more specific active LCD or billing article.

National source or issue	Operational interpretation	Required action
ESI-specific NCD	No dedicated NCD was identified in the active LCDs reviewed.	Document the applicable MAC LCD and article rather than citing "Medicare" generically.
NCD 280.14 / infusion pumps	CPT 62323 may also be used in a separate implantable infusion-pump trial context; that is not a caudal ESI for pain-management coverage.	Keep pump-trial workflows, diagnoses, and policy logic separate from caudal ESI.
Reasonable and necessary standard	The service must be medically reasonable and necessary and supported by contemporaneous documentation.	Do not treat a code appearing in an article as proof of medical necessity.
FDA status and safety communication	Corticosteroids are not FDA-approved specifically for epidural administration, and FDA has warned of rare serious neurologic events.	Maintain informed-consent, medication-governance, and safety processes; do not confuse FDA status with a payer coverage determination.
National coding rules	CPT, HCPCS, NCCI, MUE, claim form, signature, and record-retention rules apply in addition to the LCD.	Run coding and claim edits independently from authorization approval.

GoHealthcare national-policy interpretation

The correct Medicare statement is: "No ESI-specific NCD was identified; coverage is governed by the beneficiary's active MAC LCD, related article, and applicable national Medicare rules." Avoid statements such as "Medicare covers caudal ESI" or "Medicare does not require authorization." Those statements are incomplete because jurisdiction, indication, date of service, WISeR participation, and claim-review pathway can change the answer.

Back to Procedure Navigation

12

GoHealthcare MSK Specialty Procedure Library

Medicare LCDs and MAC Guidance

Medicare coverage is local. Multiple MACs maintain substantially aligned epidural steroid injection LCDs, but the policy identifier, contractor, effective date, jurisdiction, article, covered diagnoses, and implementation details must be verified for the beneficiary. The table below is a policy-management map, not a substitute for the Medicare Coverage Database state search.

MAC / active LCD example	Related article example	Policy status reviewed	Operational note
Novitas Solutions - L36920	A56681	Active revision effective 04/09/2026	Common multijurisdictional criteria; use MCD to confirm the beneficiary's state and contractor.
First Coast Service Options - L33906	A56651	Active revision effective 04/09/2026	Do not use Novitas article numbers for First Coast claims.
Palmetto GBA - L38994	A58695	Active revision effective 04/16/2026	Confirm current jurisdiction and article version before submission.
CGS Administrators - L39015	A58731	Current revision path effective in 2026	The prior version ended 04/08/2026; open the current public version for the date of service.
WPS - L39054	A58777	Active 2026 revision	Applies within WPS jurisdictions; state and contract mapping must be verified.
Noridian - L39240	A58993	Active 2026 revision	Former Noridian L39242/A58995 versions may appear in searches as retired; do not cite retired policy as current.
Other MAC policy sets	Article and LCD identifiers vary	Verify in MCD	A national procedure library should teach the verification process rather than publish an assumed state list.

Common active-LCD medical-necessity architecture

Coverage element	Common Medicare requirement	Caudal ESI documentation implication
Qualifying presentation	Concordant history, examination, and imaging support radiculopathy, radicular pain, or neurogenic claudication from an appropriate structural cause; post-laminectomy syndrome and acute zoster pain may also be addressed.	Describe the lower-extremity symptom pattern, objective findings, relevant pathology, and route rationale.
Functional severity	Pain is severe enough to cause significant functional or quality-of-life impact; baseline pain or disability measure is documented.	Record a reproducible baseline instrument and patient-specific functional restrictions.
Duration and conservative care	Common framework requires at least four weeks of pain and failure, intolerance, or inability to complete noninvasive care, subject to limited exceptions.	Provide dates, modalities, adherence, outcomes, and exception rationale.
Image guidance	Fluoroscopy or CT with contrast is generally required unless a documented contraindication applies.	Procedure note, retained images, contrast flow, and claim code must align.
Session scope	One spinal region per session; caudal/interlaminar injection is generally one level and not bilateral.	Do not append bilateral logic or multiply units based on symptomatic levels.
Repeat response	Common language requires at least 50% sustained pain relief for three months or 50% sustained functional improvement; a second injection after 14 days may be considered after an inadequate first response when a different approach, level, or medication and rationale are documented.	Capture percentage, instrument, function, duration, and the reason for the next strategy.
Frequency	Common limit is four ESI sessions per spinal region in a rolling 12 months.	Count caudal, lumbar interlaminar, and lumbar/sacral transforaminal sessions together when the policy defines one lumbosacral region.
Rehabilitation	The injection should be performed with conservative treatment and an active rehabilitation, home-exercise, or functional-restoration plan.	Connect the intervention to a defined functional objective.
Extended treatment	Use beyond 12 months generally requires additional rationale, response, ongoing need, and communication with the primary-care team.	Create a higher-level utilization review before long-term repeats.
Noncovered patterns	Predetermined series, nonspecific axial low-back pain, routine deep/moderate sedation, multiple regions, and unsupported same-day combinations are common limitations.	Use scheduling and billing hard stops.

MAC verification workflow

1. Identify whether the patient has Original Medicare, Medicare Advantage, Railroad Medicare, or another product.
2. For Original Medicare, identify the Part B MAC by state and provider jurisdiction using the Medicare Coverage Database.
3. Open the LCD version effective on the planned date of service - not merely the most recent search result.
4. Open the related billing and coding article and confirm its effective version.
5. Validate the covered-diagnosis group, utilization parameters, documentation requirements, and any claim-specific instructions.
6. Save the LCD ID, article ID, version/effective date, access date, and source URL in the authorization record.
7. Recheck the policy if the service date moves across an effective-date boundary.

Back to Procedure Navigation

13

GoHealthcare MSK Specialty Procedure Library

Medicare Billing and Coding Articles

LCDs establish medical-necessity requirements; related billing and coding articles typically hold the procedure codes, diagnosis-code groups, utilization instructions, and documentation details. The LCD and article must be read together. A procedure can satisfy the LCD narrative and still deny if the claim diagnosis is not recognized by the applicable article or if the code, units, modifier, or documentation is incorrect.

Article control	Common instruction	Operational consequence
Procedure code	CPT 62323 is the primary image-guided lumbar/sacral interlaminar or caudal code.	Authorize and bill the performed service consistently; verify the current code set.
Imaging documentation	Articles may require retained views showing final needle position and contrast flow.	Facility image-retention and procedure-note workflow must support post-payment review.
Regional/session limits	One region per session and one caudal/interlaminar level are commonly stated.	Do not use multiple units or bilateral modifiers for a single caudal ESI.
Frequency	Four sessions per region in a rolling 12 months is common.	Maintain a cross-provider regional utilization ledger when information is available.
Diagnosis list	Covered ICD-10-CM codes differ by article and version.	Use the patient's supported diagnosis and confirm it against the exact article.
Signature and records	Legible, signed records and supporting documentation must be available on request.	Resolve unsigned notes before claim release; preserve the complete episode file.
Special code use	The same CPT code can be used for other clinical contexts, such as an infusion-pump trial.	Do not apply ESI diagnosis restrictions or WISeR logic mechanically to a different indication.

Coding List Warning

A diagnosis appearing in a Medicare article means that the code may be reportable when the patient's record supports that condition and all coverage requirements are met. It does not authorize diagnosis selection for reimbursement convenience.

Back to Procedure Navigation

14

GoHealthcare MSK Specialty Procedure Library

CMS WISeR Model: Prior Authorization and Prepayment Review

CMS's Wasteful and Inappropriate Service Reduction (WISeR) Model operates from 2026 through 2031 in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. For included Original Medicare services, CPT 62323 when used for epidural steroid injection is subject to an optional prior-authorization pathway or, when prior authorization is not obtained, prepayment medical review. The model does not replace the applicable LCD; it changes the review workflow. [9]

WISeR control	Operational requirement
Population	Confirm Original Medicare and a WISeR state; do not assume the model applies to Medicare Advantage or Railroad Medicare.
Indication logic	Confirm that 62323 is being used for an epidural steroid injection, not another covered use of the code.
Review choice	Submit prior authorization before service or expect prepayment medical review when the claim enters the model pathway.
Clinical packet	Submit the same evidence required by the applicable LCD and article: qualifying diagnosis, concordant findings, conservative care, functional impact, prior response when applicable, and planned service.
Tracking identifier	Capture the unique tracking number or other required authorization identifier and reconcile it to the claim.
Resubmission / peer-to-peer	Use the current participant and MAC instructions for non-affirmed requests, resubmission, and peer-to-peer review.
Date and setting	Validate current CMS operational dates, participating reviewer, state, site-of-service workflow, and claim instructions before service.

New Jersey Priority

Because GoHealthcare operates in New Jersey, Original Medicare caudal ESI cases using CPT 62323 require an explicit WISeR checkpoint in the 2026 authorization workflow. A traditional "Medicare does not require authorization" rule is no longer operationally safe.

Back to Procedure Navigation

15

GoHealthcare MSK Specialty Procedure Library

Commercial Payer Policies

Commercial coverage must be evaluated at the member, product, state, employer-group, network, and site-of-service level. The following policies illustrate current requirements; they are not universal. Always verify whether a payer uses its own policy, a delegated UM organization, InterQual, MCG, or another proprietary criteria set.

Payer policy example	Initial criteria highlighted	Repeat / utilization rules highlighted
UnitedHealthcare Commercial and Individual Exchange - effective 06/01/2026	Radicular back pain supported by history and examination; failure of at least four weeks of conservative therapy; structural or functional nerve-root involvement by imaging or electrodiagnostic evidence; fluoroscopy or CT.	Maximum four ESI sessions per region per year. Repeat requires return of radicular pain or functional deterioration plus policy-defined prior response and reassessment.
Aetna CPB 0016 - current public policy	Radiculopathy or sciatica; exclusion of other causes; advanced imaging when indicated; at least four weeks of conservative treatment; comprehensive pain-management program.	Additional injection requires at least two specified outcome elements for at least two weeks; no more frequent than every two weeks; up to three per episode in six months and four per region in a rolling 12 months.
Humana	Criteria and delegation can be national, state-edition, product-specific, or portal-based.	Do not generalize a state-specific Humana document; verify the member's live policy and authorization channel.
Cigna	Cigna may apply eviCore/Evernorth CMM-200 for services within delegated scope.	Use the eviCore version effective on the date of service and verify whether the member's plan is in scope.
Other commercial plans	Radicular indication, functional impact, conservative care, imaging, image guidance, and route-specific coding are common.	Thresholds, timing, imaging recency, and annual limits differ; capture the exact policy version.

Commercial policy controls that frequently conflict

• Imaging. Some policies require advanced imaging or electrodiagnostic support; others permit a narrow initial lumbar caudal/interlaminar exception when the examination is clearly diagnostic.
• Conservative-care definition. Four weeks is common, but acceptable active and passive modalities, HEP supervision, adherence, and exception criteria differ.
• Repeat outcome. Policies vary between two-week, three-month, pain-only, function, medication-reduction, and combined outcome thresholds.
• Episode definition. Some reviewers define a new episode after 12 months, others after two years, and some use plan-specific logic.
• Frequency. Annual limits may be per region and include all epidural approaches; never count only CPT 62323.
• Site of service. A clinical approval may not satisfy a separate outpatient-site policy.
• Delegation. The insurer listed on the card may not be the organization making the clinical determination.

Back to Procedure Navigation

16

GoHealthcare MSK Specialty Procedure Library

Blue Cross Blue Shield Policy Perspective

"BCBS policy" is not a single national rule. Independent Blue plans use different medical policies, prior-authorization lists, proprietary criteria, InterQual, MCG, Carelon, Evolent, or internal review. A BCBS logo does not identify the governing clinical criteria. The authorization team must resolve the specific plan, alpha prefix, product, state, host/home plan relationship when relevant, and delegated reviewer.

BCBS operational example	What it demonstrates	Required practice response
BCBS Rhode Island	Public policy and preauthorization pages show plan-specific criteria and effective-date transitions; a future 2026 policy may coexist with the current policy.	Apply the version effective on the service date and do not use a draft/future policy prematurely.
Blue Cross NC	Musculoskeletal services may be managed through a delegated program such as Evolent depending on product and service.	Confirm delegation and submit through the correct portal.
Blue Cross Massachusetts	Some MSK management relies on InterQual or plan-specific program documents rather than a public procedure narrative.	Use the plan's clinical-review source and preserve the criteria screenshot or case-specific checklist when permitted.
BCBS Illinois / HCSC plans	Prior-authorization and clinical-review code lists are product- and network-specific, and policy pages state that benefits vary by plan.	Verify code, product, network, and reviewer; authorization does not guarantee payment.
Federal Employee Program and other national accounts	Separate program criteria and authorization pathways may apply.	Do not assume the local commercial plan policy controls.

BCBS Denial Prevention Rule

Document the exact Blue plan, product, alpha prefix, UM entity, policy or criteria source, effective date, and authorization reference. "BCBS approved" is not sufficient operational documentation.

Back to Procedure Navigation

17

GoHealthcare MSK Specialty Procedure Library

Delegated Utilization Management Guidelines

Delegated UM organizations apply clinical criteria only when the health plan has assigned the service and product to them. Their guidelines must never be imported into a case solely because the vendor commonly works with that insurer. Verify delegation first, then apply the version effective on the date of service.

Carelon Medical Benefits Management

Carelon element	Current 06/14/2026 guideline signal
Initial indication	Significant radicular pain, radiculopathy, or lumbar neurogenic claudication with functional impairment and completed examination.
Diagnostic evidence	MRI or CT commonly demonstrates nerve-root compression or stenosis and correlates with findings. A narrow initial lumbar caudal/interlaminar exception may permit no advanced imaging when symptoms and examination are clearly diagnostic.
Conservative care	Generally at least four weeks; two weeks may be allowed when there is clear objective radiculopathy as defined by the guideline.
Route/session	Only one caudal or interlaminar injection per session; it is not performed with a transforaminal injection.
Repeat	Prior injection generally must produce at least 50% pain reduction and functional improvement lasting at least three months. A one-time early second injection may be considered after an inadequate initial response using a changed strategy and documented rationale.
Frequency	Maximum four therapeutic ESI sessions per spinal region in a rolling 12 months.
Long-term use	Continuation beyond 12 months and prolonged steroid exposure trigger additional care-coordination expectations.

eviCore by Evernorth / Cigna CMM-200

At this resource's policy-currency date, the Cigna CMM-200 version effective February 25, 2026 is the current published policy reviewed. A successor version is published for an August 4, 2026 effective date. The service date determines which version applies. Do not use the future version before its effective date or the prior version afterward without verifying the live source.

eviCore element	Current 02/25/2026 guideline signal
Definition	Caudal ESI is performed through the sacral hiatus under fluoroscopic guidance, with contrast absent a contraindication.
Image guidance	Fluoroscopy or CT and contrast are expected, subject to documented emergent contraindication.
Frequency	Up to three sessions per episode/region in six months and no more than four sessions per region in a rolling 12 months.
Series	A scheduled "series of three" is not supported; each subsequent injection is evaluated individually.
Caudal scope	Only one spinal level in a session; the guideline notes caudal treatment of symptomatic levels below L4-L5.
Initial presumed radicular presentation	Generally at least four weeks of conservative treatment and participation in a comprehensive pain-management or rehabilitation plan.
Repeat	At least 50% radicular-pain relief for two or more weeks plus increased function/physical activity or reduced medication/additional services.
Same-day services	Generally only one invasive modality/procedure on the date of service, subject to a narrow stated exception.

Evolent

Evolent Clinical Guideline 1750 for Epidural Spine Injections was revised in December 2025 for July 2026 implementation. It applies only when contractually delegated by the member's plan. The guideline requires supporting records and uses separate initial and repeat phases.

Evolent element	2026 guideline signal
Baseline severity	Pain causing functional disability or average pain at least 6/10 related to the requested region.
Initial episode	Clinical pathway differs for acute/exacerbated radicular pain, chronic radicular pain, stenosis, and diagnostic surgical-planning use.
Repeat authorization	Every injection requires authorization; repeat criteria are divided into initial-treatment and therapeutic phases.
New episode	An injection at least two years after prior injections in the same region may be treated as a new episode; surgery or new pathology can also create a new episode.
Image guidance	Fluoroscopy is expected for caudal/interlaminar procedures in the guideline.
Contraindications	Active systemic/spinal infection, puncture-site infection, and severe stenosis causing intraspinal obstruction are highlighted.
Same-day services	Multiple interventional pain procedures on the same date are generally not medically necessary without a documented exception.

Cohere Health

Cohere publicly describes fully delegated MSK care management that includes pain management and plan-specific clinical intelligence. A publicly accessible national caudal-ESI criteria document was not identified during this review. This should not be interpreted as absence of criteria. Cohere requirements may be presented within the provider portal and can differ by health-plan delegation.

• Confirm that Cohere is the delegated reviewer for the member and code.
• Open the case-specific criteria within the portal and save the policy/version or permitted evidence of the requirements.
• Do not substitute Carelon, eviCore, or Medicare criteria when Cohere controls the review.
• Capture portal questions exactly and ensure the clinical record supports every response.
• Reconcile approval details to the payer claim requirements because a Cohere approval does not independently guarantee payment.

Back to Procedure Navigation

18

GoHealthcare MSK Specialty Procedure Library

Evidence-Based Clinical and Specialty-Society Guidelines

Clinical evidence and payer coverage answer different questions. Evidence informs whether a treatment may benefit a selected patient; payer policy determines whether the member's plan considers the service medically necessary and payable. A society guideline does not override an LCD, and a payer policy does not establish a clinical standard of care.

Source	Evidence or recommendation signal	Operational use
American Academy of Neurology systematic review, 2025	ESIs probably reduce short-term pain and disability in selected cervical/lumbar radiculopathy populations; evidence for long-term pain and for spinal stenosis is more limited. The review is not a caudal-route superiority statement.	Use balanced informed-consent and outcome expectations; avoid promising durable relief.
ASIPP comprehensive epidural guidelines, 2021	Reviews caudal, interlaminar, and transforaminal evidence across disc herniation, stenosis, post-surgery syndrome, and other chronic spinal pain conditions.	Supports clinical pathway design but must be reconciled with payer-specific criteria.
ASPN evidence-based low-back pain guideline, 2022	Addresses interventional options and patient selection within an evidence-graded framework.	Use for clinical governance and multidisciplinary pathway development.
NASS lumbar disc herniation / ESI statements	Addresses radiculopathy and approach-specific evidence; some documents are older and should be interpreted with current evidence.	Do not cite an older recommendation as current payer policy.
FDA safety communication and product labeling	Rare serious neurologic events have been reported; epidural corticosteroid use is not specifically FDA-approved.	Maintain informed consent, adverse-event readiness, medication selection governance, and documentation.
Antithrombotic guidance	Specialty guidelines stratify bleeding risk and medication management; recommendations evolve.	The treating clinician coordinates individualized management; authorization staff must not give medication-hold instructions.

Evidence communication standard

The page should describe benefit as potential and generally time-limited, not guaranteed. Success should be defined prospectively by a meaningful change in pain, function, medication use, or ability to participate in rehabilitation. When evidence is mixed - particularly for isolated stenosis, long-term benefit, or nonradicular pain - the clinical rationale and shared decision-making should be explicit.

Back to Procedure Navigation

19

GoHealthcare MSK Specialty Procedure Library

Policy and Guideline Comparison Matrix

Source	Initial conservative care	Imaging / diagnostic support	Repeat threshold	Frequency / session
Common Medicare LCD framework	Usually at least 4 weeks or documented exception	Concordant imaging; fluoroscopy/CT with contrast for procedure	Commonly at least 50% sustained pain or functional improvement for 3 months; limited 14-day alternate strategy after inadequate first injection	4 sessions/region/rolling 12 months; one region and one caudal/interlaminar level/session
UnitedHealthcare 06/01/2026	at least 4 weeks including pharmacotherapy, activity modification, PT or HEP	Structural/functional nerve-root involvement by imaging or electrodiagnostics; fluoroscopy/CT	Return of symptoms/function deterioration plus policy-defined response/reassessment	4 sessions/region/year
Aetna CPB 0016	at least 4 weeks	Rule out other causes; advanced imaging when indicated	At least two listed outcome elements for at least 2 weeks	Up to 3/episode/6 months; 4/region/rolling 12 months; at least 2 weeks apart
Carelon 06/14/2026	Usually at least 4 weeks; possible 2-week objective-radiculopathy pathway	MRI/CT generally; narrow initial lumbar caudal/interlaminar imaging exception	at least 50% pain reduction and functional improvement for at least 3 months	4 therapeutic sessions/region/rolling 12 months; one caudal/interlaminar/session
eviCore/Cigna 02/25/2026	Generally at least 4 weeks and active rehabilitation	Fluoroscopy/CT with contrast; diagnostic criteria vary by condition	at least 50% radicular relief for at least 2 weeks plus function or utilization improvement	3/episode/6 months; 4/region/rolling 12 months; no automatic series
Evolent 2026	Pathway-specific active conservative treatment	Supporting clinical documentation; fluoroscopy for caudal/interlaminar	Initial and therapeutic phases; every injection requires authorization	Plan/delegation and phase-specific; new episode commonly after 2 years
Cohere	Plan/portal-specific	Plan/portal-specific	Plan/portal-specific	Plan/portal-specific

Use the Matrix Correctly

The comparison matrix identifies differences that must be resolved. It is not a blended policy. Apply one controlling payer/UM pathway to the specific member and date of service.

Back to Procedure Navigation

20

GoHealthcare MSK Specialty Procedure Library

Prior Authorization Workflow

The authorization workflow is a closed-loop clinical and revenue-cycle process. The goal is not simply an approval; it is an approval that remains valid when the service is performed, documented, coded, and billed.

Pre-submission verification

• Confirm active eligibility, product, network, benefits, and member-specific exclusions.
• Identify Original Medicare versus Medicare Advantage and apply WISeR when applicable.
• Confirm whether prior authorization, notification, recommended review, or no preservice review applies.
• Identify the controlling payer policy or delegated UM organization.
• Check rendering provider and facility network status and site-of-service rules.
• Confirm CPT 62323, caudal/lumbar-sacral region, planned date range, provider, facility, and units.
• Review the rolling lumbosacral ESI history across caudal, interlaminar, and transforaminal approaches.
• Open the policy version effective on the planned date of service and create a criterion-level checklist.

Minimum clinical authorization packet

Packet component	Patient-specific content
Order	Caudal ESI; lumbosacral region; indication; provider; facility; planned timeframe.
Current evaluation	Symptom distribution, duration, severity, neurologic and functional findings, red-flag assessment, and physician decision-making.
Diagnosis support	Accurate diagnosis with level/region and clinical correlation; no coverage-driven coding.
Imaging/testing	Report date, relevant findings, and clinician correlation when required.
Conservative treatment	Modality, start/end dates, adherence, outcome, intolerance, contraindication, or policy-recognized exception.
Baseline outcome	Pain and/or function measure that can be repeated.
Prior ESI response	Date, approach, region, percentage and duration of pain relief, functional change, medication change, and reason for repeat.
Approach rationale	Why the caudal route is clinically appropriate rather than another epidural approach.
Treatment plan	Rehabilitation/HEP connection, outcome target, follow-up timing, and next-step logic.
Administrative data	Member, provider, facility, code, diagnosis, date range, portal fields, and supporting forms.

Submission-to-claim controls

1. Complete a second-person or automated completeness review before submission.
2. Save proof of submission, criteria version, case/reference number, and turnaround date.
3. Respond to pends by mapping the requested criterion to a specific record location.
4. Validate the written approval, including code, units, region, provider, facility, dates, and authorization identifier.
5. Place an authorization hard stop if the physician changes the approach or site of service.
6. After the procedure, reconcile the performed service and procedure note against the authorization before claim release.
7. Schedule structured outcome follow-up before any repeat request.
8. Preserve the complete episode file for appeal, audit, and recoupment defense.

Back to Procedure Navigation

21

GoHealthcare MSK Specialty Procedure Library

Clinical Documentation Requirements

The record must independently establish medical necessity. Templates can organize the note but cannot replace individualized findings and decision-making. Every authorization response should be traceable to the clinical record; portal answers should never become the only place where a key medical fact exists.

Documentation domain	Required content
Symptoms	Lower-back and lower-extremity distribution, laterality, dermatomal or clinically defined pattern, severity, duration, progression, and aggravating/relieving factors.
Examination	Focused motor, sensory, reflex, gait, tension-sign, and functional findings as clinically relevant; include meaningful negatives.
Functional impact	Specific limitations in walking, standing, sleep, work, self-care, driving, rehabilitation, or other activities.
Baseline scale	Pain and/or validated/reproducible functional instrument selected for follow-up.
Imaging correlation	Date, relevant level/pathology, and clinician explanation of concordance with symptoms.
Conservative care	Dated modalities, duration, adherence, outcome, intolerance, contraindication, or exception.
Prior procedures	Date, approach, region, provider if known, response percentage, functional improvement, duration, adverse effects, and medication change.
Route rationale	Why caudal access is appropriate for the patient's anatomy, symptoms, prior surgery, or treatment objective.
Risk assessment	Infection, neurologic red flags, anticoagulant/antiplatelet therapy, allergy/contrast, pregnancy, metabolic and immunologic considerations.
Plan	Expected outcome, rehabilitation link, follow-up interval, and decision rules for repeat, alternative treatment, or referral.

Procedure-note essentials

• Exact procedure and caudal approach; avoid ambiguous "lumbar block" language.
• Pre- and post-procedure diagnoses consistent with the clinical episode.
• Imaging modality, contrast use or documented exception, and confirmation of epidural placement.
• Medications and quantities documented accurately; NDC/lot/wastage captured when required by setting or billing workflow.
• Patient tolerance, complications, neurologic status when appropriate, and disposition.
• Post-procedure instructions and scheduled outcome follow-up.
• Clinician authentication and retained imaging/documentation required by the MAC, payer, and facility.

Back to Procedure Navigation

22

GoHealthcare MSK Specialty Procedure Library

Documentation Pearls

• Use "caudal ESI." Avoid "CESI" because it is commonly used for cervical ESI in other organizations.
• Describe measurable function. "Walking tolerance fell from 20 minutes to 5 minutes" is more useful than "function impaired."
• Correlate; do not paste. State how the imaging finding explains the symptom pattern rather than copying the MRI impression.
• Date conservative care. A therapy list without dates, adherence, and outcome cannot establish a duration requirement.
• Explain the route. Document why caudal access is chosen, particularly with post-surgical anatomy or multilevel symptoms.
• Use the same measure. Baseline and follow-up must permit a valid comparison.
• Separate pain and function. Record percentage and duration of pain relief plus specific functional change.
• Build the repeat note from the prior episode. Include prior date, approach, response, duration, and return of symptoms.
• Never manufacture exceptions. An inability to complete treatment, imaging exception, or medication contraindication must be clinically documented.
• Align the episode. Order, authorization, schedule, procedure note, code, diagnosis, and claim should use consistent terminology.

Back to Procedure Navigation

23

GoHealthcare MSK Specialty Procedure Library

CPT and HCPCS Coding

Coding must be verified against the current CPT and HCPCS code sets, payer policy, and site-of-service edits. The descriptions below are paraphrased for operational education and do not replace the licensed CPT codebook.

Code / category	Operational use for caudal ESI	Key caution
CPT 62323	Primary code for an image-guided lumbar/sacral interlaminar or caudal injection of diagnostic or therapeutic substance.	Fluoroscopy or CT guidance is integral; one caudal service is not multiplied by symptomatic levels.
CPT 62322	Lumbar/sacral interlaminar or caudal injection without imaging guidance.	Major Medicare and commercial policies generally require fluoroscopy or CT; do not substitute this code to bypass documentation or authorization.
Contrast	Used to confirm epidural placement when required and not contraindicated.	Usually part of the procedure workflow; separate payment depends on setting and payer rules.
Steroid / drug HCPCS	A drug code may be separately reportable in some settings and contracts.	Verify exact product, concentration, HCPCS, NDC, units, wastage, and bundling; do not assume office drug payment.
Imaging guidance	Included in CPT 62323.	Do not separately report integral fluoroscopic/CT guidance such as 77003 with 62323.
Sedation / anesthesia	May be separately coded only when clinically and administratively supported.	Routine moderate/deep sedation or MAC is frequently considered unnecessary or bundled; verify NCCI and payer policy.
Supplies	Most ordinary supplies are included in the procedure or facility payment.	Do not create unsupported separate charges.
Unlisted codes	Generally unnecessary for a standard caudal ESI.	An unlisted code may trigger manual review and does not correct an inaccurate procedure description.

Coding decision logic

1. Confirm the actual approach documented by the physician.
2. Confirm lumbar/sacral region and whether imaging guidance was performed.
3. Use the code that accurately represents the performed service and matches the authorization.
4. Apply diagnosis codes supported by the record and accepted under the applicable payer/article.
5. Run NCCI, MUE, payer, and site-of-service edits before claim release.
6. Reconcile any drug line to the medication administration record and inventory.
7. Hold the claim when the performed service differs from the approval until the payer's amendment or retrospective process is resolved.

Back to Procedure Navigation

24

GoHealthcare MSK Specialty Procedure Library

ICD-10-CM Crosswalk

The ICD-10-CM crosswalk is a documentation and policy-mapping tool, not a list of diagnoses to use automatically. Codes vary by Medicare article and commercial payer. Select the highest-specificity code that accurately reflects the clinician's diagnosis for the current code year, then verify that it is accepted under the governing policy. The examples below emphasize lumbar/sacral diagnoses appearing in representative Medicare article groups; they are not exhaustive or universally covered.

Clinical documentation concept	Representative ICD-10-CM examples	Documentation connection / caution
Lumbar spondylosis with radiculopathy	M47.26	Document lumbar region, radicular findings, and structural/clinical concordance.
Lumbosacral spondylosis with radiculopathy	M47.27	Use only when lumbosacral region is clinically diagnosed.
Lumbar spinal stenosis without neurogenic claudication	M48.061	Some payer indications focus on radicular pain; stenosis alone without a covered syndrome may be insufficient.
Lumbar spinal stenosis with neurogenic claudication	M48.062	Document claudication pattern, functional walking/standing limits, and imaging correlation.
Lumbar disc disorder with radiculopathy	M51.16	Document the disc pathology and lumbar radicular syndrome.
Lumbosacral disc disorder with radiculopathy	M51.17	Use when the clinician diagnoses lumbosacral disc disease with radiculopathy.
Lumbar radiculopathy	M54.16	Document symptom distribution and objective/supporting findings; avoid using for nonspecific back pain.
Lumbosacral radiculopathy	M54.17	Differentiate lumbosacral from lumbar region based on the record.
Other sacral/sacrococcygeal radiculopathy	M54.18	Use only when specifically diagnosed and supported; do not use for SI-joint or coccygeal pain.
Post-laminectomy syndrome, lumbar	M96.1	The record should identify the current radicular/neuropathic presentation; Aetna and some commercial policies may treat failed-back-surgery indications differently.
Osseous/foraminal stenosis code families	M99.23, M99.33, M99.43, M99.53, M99.63, M99.73	These codes require precise clinical and anatomic documentation and article verification.
Herpes zoster-associated pain	B02.23, B02.7, B02.8, B02.9 as applicable	Use only when the current diagnosis and policy support acute zoster-related epidural treatment; code specificity matters.
Neoplasm-related pain	G89.3 where applicable	Do not use a pain code alone when the underlying condition and coverage pathway require additional diagnosis coding.
Nonspecific axial low-back pain	Examples such as M54.50 may appear in the record	Frequently not a covered ESI indication by itself; never add radiculopathy solely for coverage.

Crosswalk validation sequence

1. Confirm the clinician's final diagnosis and region.
2. Validate the code in the current ICD-10-CM year and apply all required characters/specificity.
3. Confirm that the symptoms, examination, and imaging support the diagnosis.
4. Check the exact Medicare billing article or commercial policy for the member and date of service.
5. Use additional codes only when clinically documented and relevant to claim adjudication.
6. Reconcile the diagnosis on the authorization, procedure note, and claim.
7. Do not change the diagnosis after denial unless the original record supports a legitimate coding correction.

Back to Procedure Navigation

25

GoHealthcare MSK Specialty Procedure Library

Modifiers, Units, NCCI, MUE, and Place of Service

Claim element	Operational standard	Common error
Units	A standard caudal ESI is generally one unit of 62323 for the session.	Billing multiple units for multilevel symptoms or injectate spread.
Modifier 50 / bilateral	A caudal injection is not bilateral, and Medicare articles state that 62323 should not be reported as bilateral.	Appending modifier 50 because symptoms are bilateral.
RT/LT	The caudal approach is midline/regional; payer-specific claim fields should be followed, but side modifiers are generally not inherent to 62323.	Using laterality modifiers to force payment.
Modifier 59 / X modifiers	Use only when a truly distinct service meets coding rules and payer documentation requirements.	Using a distinct-service modifier to bypass an edit without a separate service.
Imaging	Integral to 62323.	Unbundling 77003 or other guidance.
NCCI	Run current CMS and payer edits for same-day spine procedures, imaging, sedation, drugs, and E/M services.	Assuming authorization overrides a coding edit.
MUE	Verify the current unit limit and payer implementation.	Relying on a historical unit limit or treating an MUE as a coverage policy.
POS 11	Physician office; professional and drug/supply payment depend on payer and ownership.	Using office POS for a facility service.
POS 22	Hospital outpatient; professional and facility claims are separate.	Failing to authorize the facility or site-of-service requirement.
POS 24	Ambulatory surgical center.	Assuming all payer products cover the procedure in an ASC.
Same-day E/M	Separately report only when significant, separately identifiable, and supported under current rules.	Routine pre-procedure assessment billed as separate E/M without support.

Back to Procedure Navigation

26

GoHealthcare MSK Specialty Procedure Library

Reimbursement Considerations

No evergreen national payment amount should be presented for caudal ESI. Medicare payment varies by locality, facility versus nonfacility setting, annual rulemaking, and status indicators. Commercial reimbursement is contract-specific. A valid authorization is necessary in many plans but does not establish benefit coverage or payment.

Reimbursement domain	Operational control
Professional payment	Verify the current Medicare Physician Fee Schedule or contracted rate for the provider, locality, and site of service.
ASC facility payment	Confirm that CPT 62323 is payable in the ASC for the payer/product, that the ASC is authorized and in network, and that facility documentation supports the claim.
Hospital outpatient payment	Verify the current outpatient payment classification, status indicator, facility authorization, and medical-necessity documentation.
Office economics	Account for drug acquisition, supplies, staffing, imaging equipment, authorization labor, denials, and payer-specific bundling - not only the professional allowable.
Drug payment	Reconcile exact medication, HCPCS, NDC, units, wastage, and whether the drug is bundled or separately payable.
Sedation/anesthesia	Verify whether separate anesthesia is covered and clinically supported; routine use may deny.
Patient responsibility	Estimate deductible, coinsurance, copayment, and noncovered exposure using current eligibility and benefits; disclose that authorization is not a payment guarantee.
Network and site	Provider and facility network status can independently affect payment and patient liability.
WISeR / authorization identifier	Ensure the required tracking or authorization number is present on the claim when applicable.
Post-payment review	Retain the complete medical-necessity, authorization, coding, imaging, and outcome record for audit and recoupment defense.

Revenue-integrity checkpoint

Do Not Release the Claim Until Reconciled

Compare the authorization with the performed service and claim: member, payer/product, CPT, diagnosis, provider, facility, place of service, date, units, drug lines, authorization/UTN, and documentation. Resolve every discrepancy before billing.

Back to Procedure Navigation

27

GoHealthcare MSK Specialty Procedure Library

Integrated Compliance and Quality Controls

Control	Purpose	Recommended evidence
Policy-currency log	Prevents use of archived or future criteria.	Policy title, ID, version/effective date, access date, URL, owner.
Regional utilization ledger	Prevents frequency denials across approaches and providers.	Date, region, approach, code, provider, response, payer decision.
Documentation completeness score	Identifies missing medical-necessity elements before submission.	Criterion-level audit with pass/fail/needs clarification.
Authorization reconciliation	Prevents approved-versus-performed mismatch.	Pre-service and pre-claim reconciliation record.
Outcome registry	Supports repeat requests and clinical quality.	Baseline and follow-up pain/function, duration, medication and care-pathway change.
Denial taxonomy	Separates medical necessity, authorization, coding, benefit, network, and documentation failures.	Standard denial reason and root-cause fields.
Appeal evidence map	Improves focused appeals and avoids unsupported retrospective additions.	Policy criterion mapped to contemporaneous record page/date.
Clinical governance review	Monitors long-term steroid exposure, safety, extended utilization, and outlier patterns.	Periodic physician/compliance review and action log.

Back to Procedure Navigation

28

GoHealthcare MSK Specialty Procedure Library

Denial Prevention

Denial prevention begins before the order is scheduled. The highest-value control is a criteria-driven preauthorization review that detects missing evidence while the clinician can still clarify the plan. Retrospective appeals are slower, more expensive, and less reliable than front-end documentation integrity.

Risk	Preventive control	Owner
No covered radicular indication	Clinical review confirms the diagnosis and symptom pattern before submission.	Clinician / UM nurse
Imaging not concordant or missing	Apply the member-specific imaging rule and document the clinician's correlation.	Clinician / PA specialist
Conservative care incomplete	Use dated discrete fields and verify duration, adherence, and result.	Clinical support / PA specialist
Frequency exceeded	Maintain a rolling regional ESI ledger across caudal, interlaminar, and transforaminal approaches.	PA / RCM
Repeat benefit not established	Schedule structured follow-up and use the same outcome measure.	Clinical team
Wrong UM vendor	Verify delegation by member/product/state.	Eligibility / PA
Authorization mismatch	Reconcile code, provider, facility, date range, region, and units before service.	PA / scheduler
Procedure changed on date of service	Hold claim and obtain permitted amendment or document payer direction.	Clinical / PA / billing
Missing UTN or reference number	Hard-stop claim release until the required identifier is attached.	Billing
Unsigned or cloned note	Complete authentication and clinical quality review.	Clinician / compliance

Back to Procedure Navigation

29

GoHealthcare MSK Specialty Procedure Library

Common Denial Reasons

• "Medical necessity not established." Usually reflects missing or nonconcordant diagnosis, examination, functional impact, imaging, or conservative-care evidence.
• "Conservative treatment not completed." The record lacks dates, duration, adherence, outcomes, or a recognized exception.
• "Frequency limit exceeded." Prior injections in the same lumbar/sacral region were not counted across approaches or practices.
• "Repeat criteria not met." The prior response was not measured, did not meet the payer threshold, or lacked sufficient duration.
• "Imaging does not support requested service." The report does not show a relevant lesion, or the note does not correlate the finding with symptoms.
• "Authorization not obtained / invalid." Wrong vendor, expired date range, wrong provider, wrong facility, or changed code.
• "Noncovered diagnosis." The claim diagnosis is absent from the MAC/payer list or does not support an ESI.
• "Service included or bundled." Separate imaging, drug, sedation, or other lines conflict with coding edits or payment policy.
• "Documentation not received." The payer did not receive the record within the requested timeframe or the submission proof is unavailable.
• "Experimental, investigational, or not medically necessary." May arise from route, indication, imaging method, or plan-specific policy exclusions; appeal only when the record and policy support coverage.

Back to Procedure Navigation

30

GoHealthcare MSK Specialty Procedure Library

Appeals and Peer-to-Peer Review

An appeal should address the payer's stated reason, not repeat the original packet unchanged. The first task is denial classification: administrative, benefit, coding, frequency, medical necessity, or documentation failure. The second is to determine whether the record existing at the time of service supports the requested outcome. Appeals must not create clinical facts retrospectively.

Appeal structure

1. Identify the member, claim or authorization number, service, date, provider, facility, and denial reason.
2. Quote or accurately summarize the controlling policy criterion and policy version.
3. Map each criterion to a dated location in the medical record.
4. Explain the clinical concordance among symptoms, examination, diagnostic findings, and selected caudal approach.
5. Summarize conservative treatment with dates and outcomes.
6. For a repeat, state the prior injection date, approach, percentage and duration of relief, functional improvement, and return of symptoms.
7. Address frequency history across the entire lumbar/sacral region.
8. Attach only relevant, legible, authenticated records and proof of authorization or submission.
9. Request the specific remedy: authorization, reversal, reconsideration, or corrected processing.
10. Track the deadline, method, reference number, and final outcome.

Peer-to-peer preparation

• Provide the physician reviewer with the denial rationale and exact policy before the call.
• Create a one-page case summary with the clinical syndrome, imaging correlation, conservative care, function, prior response, and approach rationale.
• Identify any true gap before the call; do not expect the peer-to-peer to replace missing documentation.
• Document the reviewer's name, date, decision, rationale, authorization number, and required follow-up.
• Under WISeR, a peer-to-peer may be requested in connection with a resubmission after non-affirmation; follow the current CMS and participant process. [5]

Back to Procedure Navigation

31

GoHealthcare MSK Specialty Procedure Library

Operational Workflow

Stage	Primary owner	Required output	Key control
1. Order entry	Clinician	Specific caudal ESI order and indication.	No vague "lumbar injection" orders.
2. Clinical readiness	Clinical support / UM nurse	Complete criteria packet and baseline measure.	Gap list returned to clinician before submission.
3. Benefits and delegation	Eligibility / PA	Benefit, network, vendor, site-of-service, and cost-share verification.	Member-product-specific verification.
4. Utilization check	PA / RCM	Rolling lumbar/sacral ESI history.	Count all approaches and locations.
5. Submission	PA specialist	Complete request with proof and case number.	Policy version and submission timestamp recorded.
6. Follow-up	PA specialist	Decision or documented escalation.	Pends answered with targeted information.
7. Authorization reconciliation	PA / scheduler	Validated approval matched to schedule.	Hard stop for mismatch or expiration.
8. Procedure	Clinician / facility	Accurate procedure and medication record.	Route and imaging documented.
9. Claim release	Coder / biller	Clean claim with authorization/UTN and correct POS.	Procedure-to-claim reconciliation.
10. Outcome follow-up	Clinical team	Pain/function response and duration.	Same baseline instrument used.
11. Denial management	RCM / clinical appeals	Root-cause-specific correction or appeal.	No generic resubmission.
12. Quality review	Leadership / compliance	Trend report and corrective action.	Closed-loop learning by payer and provider.

Recommended performance indicators

• Authorization approval rate by payer, vendor, provider, and procedure.
• First-pass approval rate without pend or peer-to-peer.
• Average turnaround time and aging by status.
• Percentage of cases with complete conservative-care data at first review.
• Percentage of repeat requests with documented pain and functional response.
• Authorization-to-claim mismatch rate.
• Denial rate per 100 caudal ESI claims and top root causes.
• Appeal overturn rate and average days to resolution.
• Frequency-limit denials and out-of-network/site-of-service denials.
• Revenue at risk and recovered by root cause.

Back to Procedure Navigation

32

GoHealthcare MSK Specialty Procedure Library

Payer Perspective

From the payer's perspective, the central question is whether the requested intervention is reasonable, necessary, appropriately timed, and likely to advance the patient's care. The reviewer is looking for a qualifying radicular condition, objective clinical support, meaningful functional impairment, completion or intolerance of conservative care, appropriate diagnostic correlation, safe and policy-concordant use of image guidance, and a defensible plan for measuring outcome.

For repeat procedures, the payer expects evidence that the prior injection produced the required magnitude and duration of benefit. A statement that the patient "did well" is not equivalent to a documented percentage of pain relief, functional improvement, and duration. Frequency rules are often regional and approach-agnostic; a practice cannot avoid a limit by switching from transforaminal to caudal coding.

Payers also distinguish clinical authorization from benefit and payment administration. Even when medical necessity is affirmed, payment can fail because of eligibility, network, facility, claim-edit, authorization identifier, or coding issues. This is why the clinical and revenue-cycle workflows must be connected.

Back to Procedure Navigation

33

GoHealthcare MSK Specialty Procedure Library

Clinical Pearls

• The clinical diagnosis should drive the approach; the approach should not drive diagnosis selection.
• Document why caudal access is appropriate for the individual patient, especially when other epidural approaches could be considered.
• Use a consistent outcome instrument before and after treatment.
• Define success in functional terms, not pain reduction alone.
• Reassess red flags and neurologic status when symptoms change.
• A repeat injection is a new clinical decision, not an automatic continuation of an order set.
• Coordinate anticoagulant and antiplatelet decisions under current specialty guidance and the prescribing clinician's direction.
• Recognize the FDA safety warning and the off-label nature of epidural corticosteroid administration in informed-consent and governance processes.
• Avoid routine sedation assumptions; document patient-specific need when sedation is considered.
• When the prior injection did not provide expected benefit, document the reassessment and why a different approach, level, medication, or alternative care is more appropriate.

Back to Procedure Navigation

34

GoHealthcare MSK Specialty Procedure Library

GoHealthcare Perspective

Caudal ESI should be managed as a longitudinal clinical and financial episode. The episode includes the initial evaluation, conservative-care record, diagnostic evidence, approach selection, payer policy, authorization, procedure documentation, outcome assessment, repeat decision, claim, and any appeal. When these functions operate in separate silos, preventable denials increase and clinical teams spend more time reconstructing the record after the fact.

The best operational design moves criteria review upstream. Before the case reaches scheduling, the organization should know whether the member requires authorization, which policy applies, whether the clinical record meets the criteria, whether regional frequency allows another session, and whether the site and provider are payable. This approach protects patient access while reducing peer-to-peer calls, cancellations, claim holds, and retrospective appeals.

GoHealthcare recommends a standardized caudal ESI readiness checklist embedded in the intake or authorization workflow, supported by payer-specific rules and a regional injection ledger. Standardization should organize evidence, not manufacture it. The clinician remains responsible for the diagnosis, approach, medical necessity, risk assessment, and treatment plan.

Back to Procedure Navigation

35

GoHealthcare MSK Specialty Procedure Library

GoHealthcare Insights

• The abbreviation problem is operationally real. "CESI" may mean caudal or cervical ESI. Controlled naming prevents wrong-code, wrong-region, and wrong-policy errors.
• Frequency is a regional concept. Track lumbar/sacral epidural sessions across caudal, interlaminar, and transforaminal approaches, not in separate code silos.
• The initial note should be appeal-ready. A record written only to obtain authorization often fails later audit or claim review. Document the full clinical rationale from the start.
• Repeat cases are outcome-data cases. The authorization team cannot reconstruct percentage, duration, and functional benefit without a structured follow-up process.
• Policy version control matters. Commercial vendors may post a future-effective guideline while the current version remains in force. Record the version applied to the planned date of service.
• WISeR changes Medicare operations in six states. For CPT 62323 ESI, Original Medicare workflows in NJ, OH, OK, TX, AZ, and WA now require active management of prior authorization or prepayment review, UTNs, and resubmission pathways.
• Authorization and reimbursement are separate controls. A clinically approved service can still deny for provider, facility, eligibility, date, code, or claim-identifier mismatch.
• The cleanest denial is the one prevented before scheduling. Front-end clinical readiness costs less than a peer-to-peer, cancellation, corrected claim, or appeal.

Back to Procedure Navigation

36

GoHealthcare MSK Specialty Procedure Library

Key Takeaways

• Caudal ESI is a lumbosacral epidural procedure through the sacral hiatus; it is not a cervical or thoracic procedure.
• The strongest coverage cases demonstrate a qualifying radicular or claudicant syndrome, objective clinical support, functional impairment, conservative treatment, and a coherent rationale for the caudal route.
• Original Medicare coverage is MAC-specific. Verify the current LCD and billing article for the beneficiary's jurisdiction.
• In six WISeR states, Original Medicare CPT 62323 used for ESI is subject to prior authorization or prepayment review operations.
• Commercial payer requirements differ in imaging prerequisites, conservative care, repeat thresholds, frequency, and site of service.
• One regional utilization ledger should count all lumbar/sacral ESI approaches.
• A repeat injection requires measured prior benefit and a new medical-necessity decision; do not schedule predetermined series.
• CPT 62323 includes imaging guidance; coding, diagnosis, provider, facility, date, and authorization must remain aligned.
• Authorization does not guarantee payment.
• Clinical documentation quality is the primary defense against denials, audits, and recoupments.

Back to Procedure Navigation

37

GoHealthcare MSK Specialty Procedure Library

Frequently Asked Questions

Is a caudal ESI the same as a sacroiliac joint injection?

No. A caudal ESI accesses the lumbosacral epidural space through the sacral hiatus. A sacroiliac joint injection targets the sacroiliac joint and has different coding, indications, and payer requirements.

Can a caudal ESI be cervical or thoracic?

No. The caudal approach is performed through the sacral hiatus into the lumbosacral epidural space. Cervical and thoracic ESIs use other approaches.

What CPT code is commonly used for an image-guided caudal ESI?

CPT 62323 is commonly used for an image-guided lumbar/sacral interlaminar or caudal injection. Verify the current CPT code set, payer policy, and procedure performed.

Is fluoroscopy or CT required?

Major Medicare and commercial policies generally require fluoroscopy or CT, commonly with contrast, subject to limited policy-specific exceptions. Verify the live policy.

Does the payer always require an MRI?

No. Requirements vary. Some policies require imaging or electrodiagnostic evidence; Carelon's 2026 guideline includes a limited initial lumbar caudal/interlaminar pathway without confirmatory advanced imaging when the presentation is clearly diagnostic of radiculopathy. Do not apply that exception to other payers.

Is isolated axial low-back pain usually covered?

Coverage is generally weak when the record documents only axial pain without a qualifying radicular syndrome or other covered indication. The member-specific policy controls.

How much conservative care is required?

Four weeks is common in Medicare and major commercial policies, but the modalities, timing, and exceptions differ. Document dates, duration, adherence, outcome, and any intolerance or contraindication.

Can the physician order a series of three injections?

A predetermined series should not be operationalized. Each repeat must satisfy the applicable response, timing, frequency, and medical-necessity requirements.

How are frequency limits counted?

Many policies count sessions per spinal region regardless of approach, side, or level. Caudal, lumbar interlaminar, and lumbar/sacral transforaminal injections may all affect the same lumbar/sacral regional limit.

What must be documented before a repeat injection?

Document the prior injection date and approach, percentage of pain relief, functional improvement, duration of benefit, return or deterioration of symptoms, current examination, and reason another injection is appropriate.

Does Medicare require prior authorization for caudal ESI?

Not nationally in every state. Under the 2026 WISeR Model, Original Medicare CPT 62323 used for ESI in NJ, OH, OK, TX, AZ, and WA is subject to a prior-authorization or prepayment-review pathway. Other Medicare jurisdictions follow their MAC coverage and review processes.

Does WISeR apply to Medicare Advantage?

No. WISeR is an Original Medicare model. Medicare Advantage plans may have their own authorization requirements.

Can the practice bill fluoroscopy separately with 62323?

Fluoroscopy or CT guidance is included in CPT 62323. Separate billing of integral guidance is generally inappropriate. Verify current coding rules and payer edits.

Is sedation routinely covered?

Usually not. Medicare LCDs and commercial policies often state that moderate or deep sedation, general anesthesia, or monitored anesthesia care is not routinely necessary for ESI. A patient-specific exception requires documentation and payer verification.

Does authorization guarantee payment?

No. Payment still depends on eligibility, benefit coverage, network status, site of service, coding, documentation, claim accuracy, and compliance with the authorization.

What is the most common preventable denial?

Incomplete documentation of medical necessity - especially conservative-care dates, imaging concordance, baseline and follow-up outcome measures, or regional frequency history - is among the most common operational causes.

What should happen if the planned approach changes on the procedure date?

The team should pause and determine whether the payer permits an amendment or requires a new authorization. The claim should not be released until the authorization and performed service are reconciled.

How often should policies be checked?

At benefit verification, before submission, and again when the date of service or policy effective date changes. Save the policy title, version, effective date, and access date in the case record.

Back to Procedure Navigation

38

GoHealthcare MSK Specialty Procedure Library

Related Procedures

• Lumbar Interlaminar Epidural Steroid Injection
• Lumbar Transforaminal Epidural Steroid Injection
• Sacral Transforaminal Epidural Steroid Injection
• Cervical Interlaminar Epidural Steroid Injection
• Thoracic Interlaminar Epidural Steroid Injection
• Cervical Transforaminal Epidural Steroid Injection
• Thoracic Transforaminal Epidural Steroid Injection
• Epidural Adhesiolysis / Percutaneous Epidural Neuroplasty
• Sacroiliac Joint Injection
• Ganglion Impar Block

Back to Procedure Navigation

39

GoHealthcare MSK Specialty Procedure Library

References and Policy Sources

Policy sources must be reverified for the member, product, jurisdiction, and date of service. Accessed July 26, 2026 unless otherwise stated.

1. Centers for Medicare & Medicaid Services. LCD L36920, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=36920
2. Centers for Medicare & Medicaid Services. Billing and Coding Article A56681, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56681
3. Centers for Medicare & Medicaid Services. LCD L33906, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=33906
4. Centers for Medicare & Medicaid Services. Billing and Coding Article A56651, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=56651
5. Centers for Medicare & Medicaid Services. LCD L38994, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38994
6. Centers for Medicare & Medicaid Services. Billing and Coding Article A58695, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58695
7. Centers for Medicare & Medicaid Services. LCD L39240, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39240
8. Centers for Medicare & Medicaid Services. Billing and Coding Article A58993, Epidural Steroid Injections for Pain Management. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58993
9. Centers for Medicare & Medicaid Innovation. WISeR Model Provider and Supplier Operational Guide, Version 6.0, April 24, 2026. https://www.cms.gov/priorities/innovation/files/wiser-provider-supplier-guide.pdf
10. UnitedHealthcare. Epidural Steroid Injections for Spinal Pain, Commercial and Individual Exchange Medical Policy 2026T0616N, effective June 1, 2026. https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/epidural-steroid-injections-spinal-pain.pdf
11. Aetna. Clinical Policy Bulletin 0016, Back Pain - Invasive Procedures. https://www.aetna.com/cpb/medical/data/1_99/0016.html
12. Carelon Medical Benefits Management. Interventional Pain Management Clinical Guidelines, effective June 14, 2026. https://guidelines.carelonmedicalbenefitsmanagement.com/interventional-pain-management-2026-06-14/
13. eviCore by Evernorth / Cigna. CMM-200 Epidural Steroid Injections, effective February 25, 2026. https://www.evicore.com/sites/default/files/clinical-guidelines/2026-02/Cigna_Epidural%20Steroid%20Inj%20%28CMM-200%29_V1.1.2025_Eff02.25.2026_pub01.30.2026_upd02.13.2026.pdf
14. Evolent. 2026 Interventional Pain Management Guidelines, Clinical Guideline 1750 for Epidural Spine Injections. https://www1.radmd.com/sites/default/files/2026-05/2026%20Evolent%20Interventional%20Pain%20Management%20Guidelines.pdf
15. Cohere Health. Musculoskeletal Prior Authorization Solutions / Delegated MSK Care Management. https://www.coherehealth.com/utilization-management/delegated/musculoskeletal-care-management
16. Blue Cross & Blue Shield of Rhode Island. Medical and Payment Policies and Preauthorization Requirements. https://www.bcbsri.com/providers/medicalpolicies
17. Blue Cross and Blue Shield of Illinois. Prior Authorization - provider requirements. https://www.bcbsil.com/provider/claims/claims-eligibility/utilization-management/prior-authorization
18. Armon C, et al.. Epidural Steroids for Cervical and Lumbar Radicular Pain and Spinal Stenosis: AAN Guidelines Subcommittee systematic review summary. Neurology. 2025;104(5):e213361. https://pubmed.ncbi.nlm.nih.gov/39938000/
19. Manchikanti L, et al.. Epidural Interventions in the Management of Chronic Spinal Pain: ASIPP Comprehensive Evidence-Based Guidelines. Pain Physician. 2021;24(S1):S27-S208. https://www.painphysicianjournal.com/current/pdf?article=NzIwNw%3D%3D&journal=134
20. American Society of Pain and Neuroscience. Evidence-Based Clinical Guideline of Interventional Treatments for Low Back Pain. Journal of Pain Research. 2022;15:3729-3832. https://pmc.ncbi.nlm.nih.gov/articles/PMC9739111/
21. U.S. Food and Drug Administration. Drug Safety Communication: rare but serious neurologic problems after epidural corticosteroid injections for pain. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-label-changes-warn-rare-serious-neurologic-problems-after
22. Narouze S, et al.. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications, Second Edition. Regional Anesthesia and Pain Medicine. 2018;43(3):225-262. https://rapm.bmj.com/content/43/3/225
23. Kao SC, Lin CS. Caudal Epidural Block: An Updated Review of Anatomy and Techniques. BioMed Research International. 2017;2017:9217145. https://pmc.ncbi.nlm.nih.gov/articles/PMC5346404/

Back to Procedure Navigation

GoHealthcare Practice Solutions

Strengthen Your MSK Prior Authorization and Revenue Cycle Performance

Connect medical necessity, payer policy, documentation, authorization, scheduling, coding, claims, denial prevention, and performance intelligence through one accountable specialty operating model.

Request Help View Our Case Studies

Case study library: https://www.gohealthcarellc.com/case-studies.html

3.5M+prior authorization requests reviewed, submitted, and processed

98%reported prior authorization approval rate

<1%of reported cases requiring peer-to-peer review

500+physicians and practice groups served

Company-reported performance metrics. Results vary by client, payer, specialty, case mix, documentation quality, and service scope; no outcome is guaranteed.

40

GoHealthcare MSK Specialty Procedure Library

Disclaimer

Professional, Clinical, Coding, and Policy Disclaimer

This resource is provided for healthcare operations, education, and general informational purposes. It does not constitute medical, legal, coding, billing, reimbursement, compliance, payer-contract, or utilization-review advice; establish a standard of care; guarantee coverage, authorization, payment, or outcome; or replace professional judgment, current licensed codebooks, official CMS instructions, the applicable MAC LCD and billing article, member-specific benefit documents, commercial payer policies, delegated UM criteria, contracts, statutes, regulations, or facility policy. Policies, codes, and payment rules change. Users must verify every requirement directly for the patient, payer, product, jurisdiction, provider, site of service, and date of service. Clinical decisions remain the responsibility of qualified treating professionals.

Developed by GoHealthcare Practice Solutions for the GoHealthcare MSK Specialty Procedure Library.

Back to Procedure Navigation